Get A Quote

Halxazone

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Others
Catalog number BBF-01314
CAS
Molecular Weight 257.24
Molecular Formula C14H11NO4

Online Inquiry

Capabilities & Facilities

Fermentation Lab

4 R&D and scale-up labs

2 Preparative purification labs

Fermentation Plant

Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)

Product Description

It is produced by the strain of Streptomyces halstedii 4029-SVS1. It is a substance that protects nerve cells. It protects PC12 cells from L-DOPA (50 X 10-6 mol/L) toxicity, and EG50 is 15.4 nmol/L. It also protects N18-RE105 cells from L-glutamate toxicity, and EG50 is 19.1 nmol/L.

  • Specification
  • Properties
  • Reference Reading
  • Price Product List
Synonyms 1-Methoxy-8-hydroxy-methyl-3H-phenoxazin-3-one
IUPAC Name 8-(hydroxymethyl)-1-methoxyphenoxazin-3-one
Canonical SMILES COC1=CC(=O)C=C2C1=NC3=C(O2)C=CC(=C3)CO
InChI InChI=1S/C14H11NO4/c1-18-12-5-9(17)6-13-14(12)15-10-4-8(7-16)2-3-11(10)19-13/h2-6,16H,7H2,1H3
InChI Key KLCVQEAOBBHOHH-UHFFFAOYSA-N
Melting Point 201-202 °C
Solubility Soluble in Methanol
1. Effect of medetomidine on respiration and minimum alveolar concentration in halothane- and isoflurane-anesthetized dogs
Phillip Lerche, William W Muir Am J Vet Res. 2006 May;67(5):782-9. doi: 10.2460/ajvr.67.5.782.
Objective: To evaluate the effect of medetomidine on minimum alveolar concentration (MAC), respiratory rate, tidal volume, minute volume (V(M)), and maximum inspiratory occlusion pressure (IOCP(max)) in halothane- and isoflurane-anesthetized dogs. Animals: 6 healthy adult dogs (3 males and 3 females). Procedure: The MAC of both inhalants was determined before and 5, 30, and 60 minutes after administration of medetomidine (5 microg/kg, IV). Dogs were subsequently anesthetized by administration of halothane or isoflurane and administered saline (0.9% NaCl) solution IV or medetomidine (5 microg/kg, IV). Respiratory variables and IOCP(max) were measured at specific MAC values 15 minutes before and 5, 30, and 60 minutes after IV administration of medetomidine while dogs breathed 0% and 10% fractional inspired carbon dioxide (FICO2). Slopes of the lines for VM/FICO2 and IOCP(max)/FICO2 were then calculated. Results: Administration of medetomidine decreased MAC of both inhalants. Slope of V(M)/FICO2 increased in dogs anesthetized with halothane after administration of medetomidine, compared with corresponding values in dogs anesthetized with isoflurane. Administration of medetomidine with a simultaneous decrease in inhalant concentration significantly increased the slope for V(M)/FICO2, compared with values after administration of saline solution in dogs anesthetized with halothane but not isoflurane. Values for IOCP(max) did not differ significantly between groups. Conclusions and clinical relevance: Equipotent doses of halothane and isoflurane have differing effects on respiration that are most likely attributable to differences in drug effects on central respiratory centers. Relatively low doses of medetomidine decrease the MAC of halothane and isoflurane in dogs.

Bio Calculators

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Recently viewed products

Online Inquiry

Copyright © 2025 BOC Sciences. All rights reserved.

cartIcon
Inquiry Basket